20h
Should Launch of Atera Spatial Biology Platform Require Action From 10x Genomics (TXG) Investors?
In April 2026, 10x Genomics launched Atera, an in situ spatial biology platform unveiled at AACR that offers ...
Enables Whole-Transcriptome In Situ Spatial Biology with Single-Cell Sensitivity at Scale. Debuts at AACR Annual Meeting 2026 ...
Zacks Investment Research on MSN
10x Genomics stock up on Atera launch, spatial biology scale enhanced
10x Genomics TXG recently unveiled Atera, a next-generation in situ spatial biology platform designed to deliver ...
SAN DIEGO--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced new updates from Bruker Spatial Biology to be showcased at the 2026 American Association for Cancer Research (AACR) Annual ...
Life science company 10x Genomics has launched Atera, a biology platform designed to deliver whole-transcriptome spatial ...
Same-slide multiomics will empower oncology researchers to simultaneously analyze the whole transcriptome (~19,000 targets) and immuno-oncology related proteins (up to 76 proteins) within the same ...
Portfolio innovations include the launch of the new CellScape XR spatial proteomics platform, the unique CosMx mouse whole transcriptome panel, the launch of the PaintScape platform for 3D genome ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed paper ...
Fei Chen and Chenlei Hu at the Broad Institute of MIT and Harvard have developed a new imaging-free spatial transcriptomics technology that tracks the diffusion of DNA barcodes between beads in an ...
CHICAGO--(BUSINESS WIRE)-- Bruker Corporation (BRKR) (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology and multiomics research at the 2025 American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results